Literature DB >> 15117457

Determination of HIV type 1 CRF01_AE gag p17 and env-V3 consensus sequences for HIV/AIDS vaccine design.

Takaichi Hamano1, Pathom Sawanpanyalert, Hideki Yanai, Surachai Piyaworawong, Takashi Hara, Sompong Sapsutthipas, Jurairat Phromjai, Shudo Yamazaki, Naoki Yamamoto, Paijit Warachit, Mitsuo Honda, Kazuhiro Matsuo.   

Abstract

A molecular epidemiological study of the gag p17 and env-V3 regions on HIV-infected drug users and blood donors was carried out in northern Thailand from 1998 through 2002 to determine the predominant subtype and consensus sequence (CS) for circulating HIV-1 strains. CRF01_AE was concluded to be a predominant strain and the nucleotide CSs in gag p17 and env-V3 showed only 1.26% and no difference from CS in the Los Alamos database, respectively. Our env-V3 CS was identical to the previously published CSs, suggesting that the CS was very conserved from 1990 through 2002 in Thailand. Gag p17 and env-V3 nucleotide sequences of seroconvertors in our subjects were quite similar to the CS and conserved for at least 9 and 6 years postinfection, respectively. These results suggest that the CS approach to the HIV-1 antigen design could overcome HIV diversity and help us develop an effective HIV/AIDS vaccine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15117457     DOI: 10.1089/088922204322996572

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  4 in total

1.  A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets.

Authors:  Brendan M Giles; Ted M Ross
Journal:  Vaccine       Date:  2011-02-12       Impact factor: 3.641

2.  A single-nucleotide synonymous mutation in the gag gene controlling human immunodeficiency virus type 1 virion production.

Authors:  Takaichi Hamano; Kazuhiro Matsuo; Yurina Hibi; Ann Florence B Victoriano; Naoko Takahashi; Yosio Mabuchi; Tsuyoshi Soji; Shinji Irie; Pathom Sawanpanyalert; Hideki Yanai; Takashi Hara; Shudo Yamazaki; Naoki Yamamoto; Takashi Okamoto
Journal:  J Virol       Date:  2006-11-22       Impact factor: 5.103

Review 3.  Viral sequence diversity: challenges for AIDS vaccine designs.

Authors:  Sean P McBurney; Ted M Ross
Journal:  Expert Rev Vaccines       Date:  2008-11       Impact factor: 5.217

4.  Hepatitis C virus antigenic convergence.

Authors:  David S Campo; Zoya Dimitrova; Jonny Yokosawa; Duc Hoang; Nestor O Perez; Sumathi Ramachandran; Yury Khudyakov
Journal:  Sci Rep       Date:  2012-02-15       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.